Feasible evaluation of neutron capture therapy for hepatocellular carcinoma using selective enhancement of boron accumulation in tumour with intra-arterial administration of boron-entrapped water-in-oil-in-water emulsion

Yanagie, Hironobu*; Kumada, Hiroaki*; Nakamura, Takemi  ; Higashi, Shushi*; Ikushima, Ichiro*; Morishita, Yasuyuki*; Shinohara, Atsuko*; Fujiwara, Mitsuteru*; Suzuki, Minoru*; Sakurai, Yoshinori*; Sugiyama, Hirotaka*; Kajiyama, Tetsuya*; Nishimura, Ryohei*; Ono, Koji*; Nakajima, Jun*; Ono, Minoru*; Eriguchi, Masazumi*; Takahashi, Hiroyuki*

In the treatment of hepatocellular carcinoma (HCC), only 30 % patients can be operated due to complication of liver cirrhosis or multiple intrahepatic tumours. Tumour cell destruction in BNCT is necessary to accumulate a sufficient quantity of B atoms in tumour cells. In this study, we prepared BSH entrapped WOW emulsion by double emulsifying technique using iodized poppy-seed oil (IPSO), BSH and surfactant, for selective intra-arterial infusion to HCC, and performed the neutron dosimetry using CT scan imaging of HCC patient. The B concentrations in VX-2 tumour obtained by delivery with WOW emulsion was superior to those by conventional IPSO mix emulsion. In case of HCC, we performed the feasibility estimation of 3D construction of tumor according to the CT imaging of a patient with epithermal neutron mode at JRR-4. Normal liver biologically weighted dose is restricted to 4.9 Gy-Eq; the max., min. and mean tumour weighted dose are 43.1, 7.3, and 21.8 Gy-Eq, respectively, in 40 minutes irradiation. In this study, we show that B entrapped WOW emulsion could be applied to novel intra-arterial boron delivery carrier for BNCT.